As a measure of analyzing the breaking of immune tolerance to CEA on a humoral level, we measured CEA antibodies by ELISA from plasma samples collected from animals, post-rAAV-CEA vaccination, plus GM-CSF adjuvant, but prior to tumor challenge. Here, CEACAM5 is linked to neoplasm.